609 related articles for article (PubMed ID: 17027182)
1. [Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].
Honderlick P; Cahen P; Gravisse J; Vignon D
Pathol Biol (Paris); 2006; 54(8-9):462-6. PubMed ID: 17027182
[TBL] [Abstract][Full Text] [Related]
2. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
Ruxer J; Mozdzan M; Loba J; Markuszewski L
Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
[TBL] [Abstract][Full Text] [Related]
3. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
Cahen P; Honderlick P
Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection.
Stein GE
Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258
[TBL] [Abstract][Full Text] [Related]
5. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
6. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
Mazzei T; Cassetta MI; Fallani S; Arrigucci S; Novelli A
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S35-41. PubMed ID: 16829051
[TBL] [Abstract][Full Text] [Related]
8. [Impact of regional guidelines on the management of urinary tract infections with antibiotics].
Ruyer O; Slekovec C; Bertrand X; Faller JP; Hoen B; Talon D; Leroy J
Med Mal Infect; 2010 Jun; 40(6):352-7. PubMed ID: 20172675
[TBL] [Abstract][Full Text] [Related]
9. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture.
Nys S; van Merode T; Bartelds AI; Stobberingh EE
J Antimicrob Chemother; 2006 May; 57(5):955-8. PubMed ID: 16554337
[TBL] [Abstract][Full Text] [Related]
10. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol.
Ungheri D; Albini E; Belluco G
J Chemother; 2002 Jun; 14(3):237-40. PubMed ID: 12120876
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
[TBL] [Abstract][Full Text] [Related]
12. [Comparative susceptibility evolution in Escherichia coli from urinary tract infections in outpatients and inpatients at Perpignan hospital in 2002 and 2004].
Lemort ML; Neuville S; Medus M; Gueudet P; Saada M; Aumaître H; Lecaillon E
Pathol Biol (Paris); 2006; 54(8-9):427-30. PubMed ID: 17027183
[TBL] [Abstract][Full Text] [Related]
13. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
[TBL] [Abstract][Full Text] [Related]
14. Urinary tract infection: traditional pharmacologic therapies.
Nicolle LE
Dis Mon; 2003 Feb; 49(2):111-28. PubMed ID: 12601341
[TBL] [Abstract][Full Text] [Related]
15. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
Aykut Arca E; Karabiber N
Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
[TBL] [Abstract][Full Text] [Related]
16. [Choice of antibiotics in uncomplicated cystitis; application of 'system of objectified judgement analysis' (SOJA) method].
Janknegt R; van den Broek PJ; Kullberg BJ; Stobberingh E
Ned Tijdschr Geneeskd; 1999 Dec; 143(49):2466-71. PubMed ID: 10608985
[TBL] [Abstract][Full Text] [Related]
17. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
[TBL] [Abstract][Full Text] [Related]
18. [Urinary tract infections: cystitis, pyelonephritis, urosepsis].
Fünfstück R; Wagenlehner FM; Olschläger T; Naber KG
Dtsch Med Wochenschr; 2012 Feb; 137(5):198-201. PubMed ID: 22278690
[No Abstract] [Full Text] [Related]
19. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
[TBL] [Abstract][Full Text] [Related]
20. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.
Gupta K; Hooton TM; Stamm WE
J Antimicrob Chemother; 2005 Jul; 56(1):243-6. PubMed ID: 15911548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
